I‐SPY2 trial yields first results on combination therapy for triple‐negative breast cancer
PulseAugur coverage of I‐SPY2 trial yields first results on combination therapy for triple‐negative breast cancer — every cluster mentioning I‐SPY2 trial yields first results on combination therapy for triple‐negative breast cancer across labs, papers, and developer communities, ranked by signal.
3 day(s) with sentiment data
-
New radiomic framework disentangles voxel geometry from signal modification in CT/MRI
Researchers have developed a new radiomic framework that accounts for voxel spacing in medical imaging, specifically computed tomography (CT) and magnetic resonance imaging (MRI). This voxel-spacing-aware (VS) method ai…
-
Pretreatment MRI reveals hidden breast cancer phenotype
Researchers have identified a latent structural phenotype in pretreatment MRI scans that influences breast cancer treatment outcomes, independent of molecular subtypes. This phenotype, termed structural entropy, was fou…
-
New AI Framework Predicts Therapeutic Response Using Gene Expression Data
Researchers have developed PREDIKTOR, a novel multi-view framework designed to predict patient-specific therapeutic response using gene expression data. This framework aligns a personalized gene regulatory network with …